A Comparative Study between a Calcium Channel Blocker (Nicardipine) and a Combined {Alpha}-ß-Blocker (Labetalol) for the Control of Emergence Hypertension During Craniotomy for Tumor Surgery
We compared the efficacy of the combination of enalaprilat/labetalol with that of enalaprilat/nicardipine to prevent emergence postcraniotomy hypertension. A prospective, randomized open labeled clinical trial was designed to compare the incidence of breakthrough hypertension (systolic blood pressur...
Saved in:
Main Authors: | Kross, R., Ferri, E., Leung, Denis H. Y., Pratila, M., Broad, C., Veronesi, M., Melendez, J. A. |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2000
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/soe_research/12 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
Similar Items
-
Cutaneous adverse reactions to calcium channel blockers
by: Papapit Tuchinda, et al.
Published: (2018) -
The current status of Beta-blockers in the treatment of hypertension (II)
by: Lock, C.B.
Published: (2016) -
Role of α1-blockers in the current management of hypertension
by: Li H.
Published: (2023) -
IV labetalol in the management of severe hypertension
by: Ee, B., et al.
Published: (2015) -
Hypertension and COVID-19: Potential use of beta-blockers and a call for Randomized Evidence
by: Mochamad Yusuf Alsagaff, -, et al.
Published: (2021)